{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:01:02Z","timestamp":1790830862956,"version":"4.1.0"},"reference-count":25,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Case Reports"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Idiopathic multicentric Castleman disease (TAFRO subtype) can mimic common differentials. High suspicion is required for chronic systemic symptoms and generalized lymphadenopathy. As fine\u2010needle aspiration is often non\u2010diagnostic, early excisional biopsy is important. Rituximab\u2010based therapy represents a guideline\u2010supported alternative when anti\u2010IL\u20106 treatment is unavailable or not feasible.<\/jats:p>","DOI":"10.1002\/ccr3.73663","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:52:07Z","timestamp":1790830327000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rethinking Common Diagnoses: Idiopathic Multicentric Castleman Disease Presenting as\n                    <scp>TAFRO<\/scp>\n                    Syndrome: A Case Report"],"prefix":"10.1002","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6290-6776","authenticated-orcid":false,"given":"Divita","family":"Rohatgi","sequence":"first","affiliation":[{"name":"Internal Medicine Hamdard Institute of Medical Sciences and Research  Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9061-5920","authenticated-orcid":false,"given":"Annesha","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Internal Medicine Maulana Azad Medical College  Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5486-0229","authenticated-orcid":false,"given":"Sourav","family":"Kumar","sequence":"additional","affiliation":[{"name":"Internal Medicine Maulana Azad Medical College  Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Rohatgi","sequence":"additional","affiliation":[{"name":"Internal Medicine Maulana Azad Medical College  Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"1","key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.hoc.2017.09.004","article-title":"Pathology of Castleman Disease","volume":"32","author":"Wu D.","year":"2018","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"4","key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/2278-0513.134505","article-title":"Castleman's Disease: A Case Report of the Unicentric Type","volume":"3","author":"Dastidar A.","year":"2014","journal-title":"Clinical Cancer Investigation Journal"},{"issue":"12","key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, Evidence\u2010Based Consensus Diagnostic Criteria for HHV\u20108\u2010Negative\/Idiopathic Multicentric Castleman Disease","volume":"129","author":"Fajgenbaum D. C.","year":"2017","journal-title":"Blood"},{"issue":"10","key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/ajh.26292","article-title":"Validated International Definition of the Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly Clinical Subtype (TAFRO) of Idiopathic Multicentric Castleman Disease","volume":"96","author":"Nishimura Y.","year":"2021","journal-title":"American Journal of Hematology"},{"issue":"5","key":"e_1_2_10_6_1","first-page":"1705","article-title":"Distinct Interleukin\u20106 Production in IPL and TAFRO Subtypes of Idiopathic Multicentric Castleman Disease","volume":"111","author":"Nishikori A.","year":"2026","journal-title":"Haematologica"},{"issue":"8","key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/bloodadvances.2024014391","article-title":"Characterizing the Heterogeneity of Castleman Disease and Oligocentric Subtype: Findings From the ACCELERATE Registry","volume":"9","author":"Pierson S. K.","year":"2025","journal-title":"Blood Advances"},{"issue":"5","key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/bjh.19334","article-title":"Idiopathic Multicentric Castleman Disease (iMCD)\u2010Idiopathic Plasmacytic Lymphadenopathy: A Distinct Subtype of iMCD\u2010Not Otherwise Specified With Different Clinical Features and Better Survival","volume":"204","author":"Gao Y. H.","year":"2024","journal-title":"British Journal of Haematology"},{"issue":"16","key":"e_1_2_10_9_1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman Disease","volume":"135","author":"Dispenzieri A.","year":"2020","journal-title":"Blood"},{"issue":"2","key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic Analysis of TAFRO Syndrome Demonstrates a Distinct Subtype of HHV\u20108\u2010Negative Multicentric Castleman Disease","volume":"91","author":"Iwaki N.","year":"2016","journal-title":"American Journal of Hematology"},{"issue":"21","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1182\/bloodadvances.2023010745","article-title":"Treatment Consistent With Idiopathic Multicentric Castleman Disease Guidelines Is Associated With Improved Outcomes","volume":"7","author":"Pierson S. K.","year":"2023","journal-title":"Blood Advances"},{"issue":"3","key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/bjh.17868","article-title":"Characteristics of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis and Organomegaly Syndrome: A Retrospective Study From a Large Western Cohort","volume":"196","author":"Maisonobe L.","year":"2022","journal-title":"British Journal of Haematology"},{"issue":"1","key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12882-019-1574-9","article-title":"TAFRO Syndrome as a Cause of Glomerular Microangiopathy: A Case Report and Literature Review","volume":"20","author":"Nagayama Y.","year":"2019","journal-title":"BMC Nephrology"},{"issue":"8","key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized Anti\u2010Interleukin\u20106 Receptor Antibody Treatment of Multicentric Castleman Disease","volume":"106","author":"Nishimoto N.","year":"2005","journal-title":"Blood"},{"issue":"23","key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1200\/JCO.2009.27.2377","article-title":"Siltuximab, a Novel Anti\u2010Interleukin\u20106 Monoclonal Antibody, for Castleman's Disease","volume":"28","author":"Van Rhee F.","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1172\/JCI126091","article-title":"Identifying and Targeting Pathogenic PI3K\/AKT\/mTOR Signaling in IL\u20106\u2010Blockade\u2010Refractory Idiopathic Multicentric Castleman Disease","volume":"129","author":"Fajgenbaum D. C.","year":"2019","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/art.43269","article-title":"Expert Perspective: Diagnosis and Treatment of Castleman Disease","volume":"78","author":"Chen L. Y. C.","year":"2026","journal-title":"Arthritis & Rhematology"},{"issue":"2","key":"e_1_2_10_18_1","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-006547","article-title":"Potential Stratification of TAFRO Syndrome by Anti\u2010SS\u2010A Antibodies Status and Therapeutic Response to Rituximab","volume":"12","author":"Suzuki T.","year":"2026","journal-title":"RMD Open"},{"issue":"9","key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for Multicentric Castleman's Disease: A Randomised, Double\u2010Blind, Placebo\u2010Controlled Trial","volume":"15","author":"Rhee F.","year":"2014","journal-title":"Lancet Oncology"},{"issue":"20","key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","article-title":"International, Evidence\u2010Based Consensus Treatment Guidelines for Idiopathic Multicentric Castleman Disease","volume":"132","author":"Van Rhee F.","year":"2018","journal-title":"Blood"},{"issue":"1","key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3960\/jslrt.53.95","article-title":"Complete Resolution of TAFRO Syndrome (Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis and Organomegaly) After Immunosuppressive Therapies Using Corticosteroids and Cyclosporin A: A Case Report","volume":"53","author":"Inoue M.","year":"2013","journal-title":"Journal of Clinical and Experimental Hematopathology"},{"issue":"1","key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/14397595.2016.1206243","article-title":"A Case of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, Successfully Treated With Corticosteroid and Cyclosporine A","volume":"29","author":"Takasawa N.","year":"2019","journal-title":"Modern Rheumatology"},{"issue":"23","key":"e_1_2_10_23_1","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011045","article-title":"Successful Treatment With Tacrolimus in TAFRO Syndrome: Two Case Reports and Literature Review","volume":"97","author":"Shirai T.","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"e_1_2_10_24_1","volume-title":"NCCN Clinical Practice Guidelines in Oncology: Castleman Disease. Version 2.2026","author":"National Comprehensive Cancer Network","year":"2026"},{"issue":"4","key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/rheumatology\/keac481","article-title":"Idiopathic Multicentric Castleman Disease and Associated Autoimmune and Autoinflammatory Conditions: Practical Guidance for Diagnosis","volume":"42","author":"Gonz\u00e1lez Garc\u00eda A.","year":"2023","journal-title":"Rheumatology (Oxford, England)"},{"issue":"7","key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3324\/haematol.2023.283603","article-title":"Longitudinal, Natural History Study Reveals the Disease Burden of Idiopathic Multicentric Castleman Disease","volume":"109","author":"Sarmiento Bustamante M.","year":"2024","journal-title":"Haematologica"}],"container-title":["Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.73663","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ccr3.73663","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.73663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:52:22Z","timestamp":1790830342000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccr3.73663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1002\/ccr3.73663"],"URL":"https:\/\/doi.org\/10.1002\/ccr3.73663","archive":["Portico"],"relation":{},"ISSN":["2050-0904","2050-0904"],"issn-type":[{"value":"2050-0904","type":"print"},{"value":"2050-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"2026-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e73663"}}